Access cutting-edge atopic dermatitis treatment through this clinical trial at a research site in Savannah. Study-provided care at no cost to qualified participants.
Access atopic dermatitis specialists in Savannah at no cost
This study follows strict safety protocols and ethical guidelines
All study-related atopic dermatitis treatment provided free
Atopic dermatitis (AD) is a skin condition that may cause a rash and itching due to inflammation of the skin. Topical therapies applied over the skin may not be enough to control the AD in trial participants who require systemic anti-inflammatory treatment. This study compares upadacitinib to dupilumab in pediatric participants with moderate to severe AD who are candidates for systemic therapy. Adverse events and change in the disease activity will be assessed. Upadacitinib is an approved drug
Sponsor: AbbVie
Check if you qualify for this atopic dermatitis clinical trial in Savannah, GA
If you're searching for atopic dermatitis treatment options in Savannah, GA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Savannah research site is actively enrolling participants for this clinical trial. You'll receive care from experienced atopic dermatitis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.